Correlation Between Aadi Bioscience and Immix Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aadi Bioscience and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aadi Bioscience and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aadi Bioscience and Immix Biopharma, you can compare the effects of market volatilities on Aadi Bioscience and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aadi Bioscience with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aadi Bioscience and Immix Biopharma.

Diversification Opportunities for Aadi Bioscience and Immix Biopharma

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Aadi and Immix is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Aadi Bioscience and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Aadi Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aadi Bioscience are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Aadi Bioscience i.e., Aadi Bioscience and Immix Biopharma go up and down completely randomly.

Pair Corralation between Aadi Bioscience and Immix Biopharma

Given the investment horizon of 90 days Aadi Bioscience is expected to generate 2.48 times less return on investment than Immix Biopharma. But when comparing it to its historical volatility, Aadi Bioscience is 3.18 times less risky than Immix Biopharma. It trades about 0.21 of its potential returns per unit of risk. Immix Biopharma is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  172.00  in Immix Biopharma on September 13, 2024 and sell it today you would earn a total of  41.00  from holding Immix Biopharma or generate 23.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Aadi Bioscience  vs.  Immix Biopharma

 Performance 
       Timeline  
Aadi Bioscience 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aadi Bioscience are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental indicators, Aadi Bioscience demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Immix Biopharma 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Immix Biopharma are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Immix Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Aadi Bioscience and Immix Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aadi Bioscience and Immix Biopharma

The main advantage of trading using opposite Aadi Bioscience and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aadi Bioscience position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.
The idea behind Aadi Bioscience and Immix Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets